Live Breaking News & Updates on Thorne Healthtech Company Profile Get Rating

Stay updated with breaking news from Thorne healthtech company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Critical Contrast: Astellas Pharma (OTCMKTS:ALPMY) vs. Thorne HealthTech (NASDAQ:THRN)

Astellas Pharma (OTCMKTS:ALPMY – Get Rating) and Thorne HealthTech (NASDAQ:THRN – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Analyst Ratings This is a summary of recent recommendations and […] ....

New York , United States , Betanis Myrbetriq , Astellas Pharma , Thorne Healthtech , Harnal Omnic , Advagraf Graceptor , Minovia Therapeutics Ltd , Cytokinetics Incorporated , Thorne Healthtech Inc , Zenith Epigenetics Ltd , Cytomx Therapeutics Inc , Entertainment Inc , Merck Co Inc , Astellas Pharma Inc , Harvard University , Actinium Pharmaceuticals Inc , Thorne Healthtech Company Profile Get Rating , Astellas Pharma Company Profile Get Rating , Get Rating , Given Thorne Healthtech , Pharma Company Profile , Cytomx Therapeutics , Actinium Pharmaceuticals , Antibody Warhead Enabling , Zenith Epigenetics ,

Thorne HealthTech (THRN) to Release Quarterly Earnings on Wednesday

Thorne HealthTech (NASDAQ:THRN – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 11th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Thorne HealthTech has set its FY 2022 guidance at EPS.Parties that are interested in registering for the company’s […] ....

United States , Thorne Healthtech , Salonis Varma , Northern Trust Corp , Geode Capital Management , Securities Exchange Commission , Thorne Healthtech Inc , Zacks Investment Research , Blackrock Inc , Renaissance Technologies , Thorne Healthtech Company Profile Get Rating , Squarepoint Ops , Get Rating , Director Saloni , Exchange Commission , Trust Corp , Healthtech Company Profile , Nasdaq Thrn ,

Thorne HealthTech, Inc. (NASDAQ:THRN) Director Saloni S. Varma Acquires 9,223 Shares

Thorne HealthTech, Inc. (NASDAQ:THRN – Get Rating) Director Saloni S. Varma bought 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average price of $6.01 per share, with a total value of $55,430.23. The acquisition was disclosed in a filing with the Securities […] ....

New York , United States , Thorne Healthtech , Salonis Varma , York State Common Retirement Fund , Securities Exchange Commission , Thorne Healthtech Inc , Zacks Investment Research , Nuveen Asset Management , Deutsche Bank , Thorne Healthtech Company Profile Get Rating , Wells Fargo Company , Brown Advisory Inc , Get Rating , Director Saloni , Exchange Commission , Asset Management , New York State Common Retirement Fund , Healthtech Company Profile , Nasdaq Thrn , Insider Trading , Nsider Trades ,

Thorne Healthtech (NASDAQ:THRN) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Thorne Healthtech (NASDAQ:THRN – Get Rating) posted its earnings results on Monday. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03, Yahoo Finance reports. Thorne Healthtech updated its FY 2022 guidance to EPS. Shares of THRN stock opened at $4.73 on Wednesday. The business’s 50-day moving average price […] ....

Thorne Healthtech , Northern Trust Corp , Geode Capital Management , Zacks Investment Research , Renaissance Technologies , Blackrock Inc , Thorne Healthtech Company Profile Get Rating , Squarepoint Ops , Get Rating , Yahoo Finance , Trust Corp , Healthtech Company Profile , Nasdaq Thrn ,